James D. Lord

2.9k total citations
40 papers, 1.8k citations indexed

About

James D. Lord is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, James D. Lord has authored 40 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 13 papers in Oncology and 13 papers in Genetics. Recurrent topics in James D. Lord's work include Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (19 papers) and Inflammatory Bowel Disease (13 papers). James D. Lord is often cited by papers focused on Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (19 papers) and Inflammatory Bowel Disease (13 papers). James D. Lord collaborates with scholars based in United States, South Africa and Australia. James D. Lord's co-authors include Brad H. Nelson, Philip D. Greenberg, Bryan C. McIntosh, Donna Shows, Monique Yoakim, James J. Moon, Hiroyuki Maeda, Benjamin G. Neel, Haihua Gu and Paul L. Bollyky and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

James D. Lord

38 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James D. Lord United States 21 1.0k 633 536 271 173 40 1.8k
Makoto Yoshimitsu Japan 23 633 0.6× 429 0.7× 567 1.1× 124 0.5× 240 1.4× 102 1.7k
Ariane Plet France 20 1.1k 1.1× 640 1.0× 757 1.4× 133 0.5× 120 0.7× 36 2.0k
Ann L. Cornish Australia 19 1.5k 1.5× 1.2k 1.8× 812 1.5× 207 0.8× 142 0.8× 20 2.4k
Claudia Curcio Italy 27 796 0.8× 570 0.9× 625 1.2× 172 0.6× 79 0.5× 61 2.0k
Woong‐Kyung Suh Canada 23 1.2k 1.2× 505 0.8× 573 1.1× 92 0.3× 169 1.0× 41 1.8k
Linda Diehl Germany 25 1.6k 1.6× 641 1.0× 587 1.1× 138 0.5× 439 2.5× 49 2.5k
Barbara Marinari Italy 18 778 0.8× 425 0.7× 709 1.3× 182 0.7× 153 0.9× 27 1.7k
Laura Patrussi Italy 21 737 0.7× 297 0.5× 637 1.2× 179 0.7× 94 0.5× 46 1.5k
Beom K. Choi South Korea 29 1.9k 1.9× 882 1.4× 460 0.9× 146 0.5× 174 1.0× 70 2.6k
Osamu Shimozato Japan 23 927 0.9× 680 1.1× 500 0.9× 214 0.8× 92 0.5× 61 1.6k

Countries citing papers authored by James D. Lord

Since Specialization
Citations

This map shows the geographic impact of James D. Lord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Lord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Lord more than expected).

Fields of papers citing papers by James D. Lord

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D. Lord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Lord. The network helps show where James D. Lord may publish in the future.

Co-authorship network of co-authors of James D. Lord

This figure shows the co-authorship network connecting the top 25 collaborators of James D. Lord. A scholar is included among the top collaborators of James D. Lord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James D. Lord. James D. Lord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jelinsky, Scott A., Isac Lee, Mara Monetti, et al.. (2024). Proteomic Differences in Colonic Epithelial Cells in Ulcerative Colitis Have an Epigenetic Basis. Gastro Hep Advances. 3(6). 830–841. 2 indexed citations
2.
Boden, Elisa K., et al.. (2023). Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells. Inflammatory Bowel Diseases. 30(5). 704–717. 2 indexed citations
3.
DeBerg, Hannah A., et al.. (2022). MAdCAM-1 Costimulates T Cells through Integrin α4β7 to Cause Gene Expression Events Resembling Costimulation through CD28. ImmunoHorizons. 6(3). 211–223. 5 indexed citations
4.
Lee, Hyun Seok, Michael Chiorean, Elisa K. Boden, et al.. (2021). Usefulness of Fluoroscopy for Endoscopic Balloon Dilation of Crohn’s Disease-Related Strictures. Digestive Diseases and Sciences. 67(4). 1295–1302. 4 indexed citations
5.
Boden, Elisa K., et al.. (2020). Escherichia coli–Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn’s Disease. Cellular and Molecular Gastroenterology and Hepatology. 10(3). 507–526. 7 indexed citations
6.
Lord, James D., S. Alice Long, Donna Shows, et al.. (2018). Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotype. Clinical Immunology. 193. 24–32. 21 indexed citations
7.
Konnikova, Liza, Gilles Boschetti, Adeeb Rahman, et al.. (2018). High-dimensional immune phenotyping and transcriptional analyses reveal robust recovery of viable human immune and epithelial cells from frozen gastrointestinal tissue. Mucosal Immunology. 11(6). 1684–1693. 25 indexed citations
8.
Boden, Elisa K., Donna Shows, Michael Chiorean, & James D. Lord. (2018). Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease. Digestive Diseases and Sciences. 63(9). 2419–2429. 45 indexed citations
9.
Kutlu, Burak, Brian A. Fox, Kyle Serikawa, et al.. (2015). High-Resolution Gene Expression Profiling Using RNA Sequencing in Patients With Inflammatory Bowel Disease and in Mouse Models of Colitis. Journal of Crohn s and Colitis. 9(6). 492–506. 51 indexed citations
10.
Lord, James D.. (2015). Promises and paradoxes of regulatory T cells in inflammatory bowel disease. World Journal of Gastroenterology. 21(40). 11236–11236. 40 indexed citations
11.
Lord, James D., et al.. (2014). T cell-associated α4β7 but not α4β1 integrin is required for the induction and perpetuation of chronic colitis. Mucosal Immunology. 7(6). 1354–1365. 30 indexed citations
12.
McElrath, M. Juliana, Kimberly S. Smythe, Julie Randolph‐Habecker, et al.. (2013). Comprehensive Assessment of HIV Target Cells in the Distal Human Gut Suggests Increasing HIV Susceptibility Toward the Anus. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(3). 263–271. 46 indexed citations
13.
Lord, James D., et al.. (2012). Paradoxically Increased FOXP3+ T Cells in IBD Do Not Preferentially Express the Isoform of FOXP3 Lacking Exon 2. Digestive Diseases and Sciences. 57(11). 2846–2855. 36 indexed citations
14.
Lord, James D., Robert C. Hackman, Ted Gooley, et al.. (2010). Blood and Gastric FOXP3+ T Cells Are Not Decreased in Human Gastric Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 17(4). 486–496. 20 indexed citations
15.
Lord, James D., Melissa P. Upton, & Joo Ha Hwang. (2010). Confocal endomicroscopic evaluation of colorectal squamous metaplasia and dysplasia in ulcerative colitis. Gastrointestinal Endoscopy. 73(5). 1064–1066. 1 indexed citations
16.
Lord, James D., Robert C. Hackman, John A. Thompson, et al.. (2009). Refractory Colitis Following Anti-CTLA4 Antibody Therapy: Analysis of Mucosal FOXP3+ T Cells. Digestive Diseases and Sciences. 55(5). 1396–1405. 84 indexed citations
17.
Parijs, Luk Van, Yosef Refaeli, James D. Lord, et al.. (2009). Uncoupling IL-2 Signals that Regulate T Cell Proliferation, Survival, and Fas-Mediated Activation-Induced Cell Death. Immunity. 30(4). 611–611. 4 indexed citations
18.
Martino, Anthony, James H. Holmes, James D. Lord, James Moon, & Brad H. Nelson. (2001). Stat5 and Sp1 Regulate Transcription of the Cyclin D2 Gene in Response to IL-2. The Journal of Immunology. 166(3). 1723–1729. 90 indexed citations
19.
Lord, James D., Bryan C. McIntosh, Philip D. Greenberg, & Brad H. Nelson. (2000). The IL-2 Receptor Promotes Lymphocyte Proliferation and Induction of the c- myc, bcl-2, and bcl-x Genes Through the trans- Activation Domain of Stat5. The Journal of Immunology. 164(5). 2533–2541. 202 indexed citations
20.
Hunt, Abigail E., Ferdinand Lali, James D. Lord, et al.. (1999). Role of Interleukin (IL)-2 Receptor β-Chain Subdomains and Shc in p38 Mitogen-activated Protein (MAP) Kinase and p54 MAP Kinase (Stress-activated Protein Kinase/c-Jun N-terminal Kinase) Activation. Journal of Biological Chemistry. 274(11). 7591–7597. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Makoto Yoshimitsu Breakdown of academic impact, for papers by Ariane Plet Breakdown of academic impact, for papers by Ann L. Cornish Breakdown of academic impact, for papers by Claudia Curcio Breakdown of academic impact, for papers by Woong‐Kyung Suh Breakdown of academic impact, for papers by Linda Diehl Breakdown of academic impact, for papers by Barbara Marinari Breakdown of academic impact, for papers by Laura Patrussi Breakdown of academic impact, for papers by Beom K. Choi Breakdown of academic impact, for papers by Osamu Shimozato
Rankless by CCL
2026